Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
|
|
Alaunos Therapeutics, Inc. (ZIOP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| MSD Partners, L.P. reports a 7% stake in Alaunos Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT reports a 6.7% stake in Alaunos Therapeutics, Inc. |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 3.8% stake in Alaunos Therapeutics Inc. |
| 01/20/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT reports a 6.2% stake in Alaunos Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Hardie Robert D. reports a 4.8% stake in ZIOPHARM ONCOLOGY, INC. |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 5.4% stake in ZIOPHARM Oncology Inc. |
| 02/02/2022 |
SC 13G/A
| BlackRock Inc. reports a 7.8% stake in ZIOPHARM ONCOLOGY INC |
| 10/12/2021 |
SC 13G/A
| MILLER VALUE PARTNERS, LLC reports a 1.7% stake in Ziopharm Oncology, Inc. |
| 02/16/2021 |
SC 13G/A
| Hardie Robert D. reports a 4.9% stake in ZIOPHARM ONCOLOGY, INC. |
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/18/2020 |
SC 13G/A
| WHITE ROCK CAPITAL MANAGEMENT LP reports a 4.5% stake in ZIOPHARM Oncology, Inc. |
| 02/14/2020 |
SC 13G/A
| MSD Partners, L.P. reports a 7.3% stake in Ziopharm Oncology, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2020 |
SC 13G/A
| BlackRock Inc. reports a 6.9% stake in ZIOPHARM ONCOLOGY INC |
| 01/30/2020 |
SC 13G/A
| WHITE ROCK CAPITAL MANAGEMENT LP reports a 7% stake in ZIOPHARM Oncology, Inc. |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2019 |
SC 13G/A
| VANGUARD GROUP INC reports a 3.9% stake in ZIOPHARM Oncology Inc |
| 02/06/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/23/2018 |
SC 13G/A
| BlackRock Inc. reports a 6% stake in ZIOPHARM ONCOLOGY INC |
| 02/14/2012 |
SC 13G/A
| ZIOPHARM ONCOLOGY INC reports a 2.9% stake in ZIOPHARM Oncology, Inc. |
| 02/14/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/13/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/08/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/14/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/11/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/10/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/16/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/19/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/13/2008 |
SC 13G/A
| ROSENWALD LINDSAY A MD reports a 3.6% stake in ZIOPHARM Oncology, Inc. |
|
|
|